Nociceptin

No|ci|cep|tin [lat. nocere = schädigen, receptare = bei sich aufnehmen; -in (3)], das; -s, -e: ein niedermol. Peptid mit 17 Aminosäuren, das am raschen Reaktions- u. Lernvermögen sowie an der Schmerzwahrnehmung beteiligt ist.

Universal-Lexikon. 2012.

Schlagen Sie auch in anderen Wörterbüchern nach:

  • Nociceptin — Other names Orphanin FQ Identifiers …   Wikipedia

  • nociceptin — noun An neuralogically active oligopeptide related to the opioids …   Wiktionary

  • nociceptin — no·ci·cep·tin (no″sĭ sepґtin) a 17–amino acid neuropeptide that binds to orphan opioid receptors but not to regular opioid receptors and has analgesic properties Called also orphanin FQ …   Medical dictionary

  • Nociceptin receptor — Opiate receptor like 1 Identifiers Symbols OPRL1; KOR 3; MGC34578; NOCIR; OOR; ORL1 External IDs …   Wikipedia

  • JTC-801 — drugbox IUPAC name = N (4 amino 2 methylquinolin 6 yl) 2 [(4 ethylphenoxy)methyl] benzamide width = 200 CAS number = 244218 51 7 synonyms = JTC 801 ATC prefix = ATC suffix = PubChem = 5311339 DrugBank = C = 26 | H = 25 | N = 3 | O = 2 molecular… …   Wikipedia

  • Opioid receptor — Opioid receptors are a group of G protein coupled receptors with opioids as ligands.[1][2][3] The endogenous opioids are dynorphins, enkephalins, endorphins, endomorphins and nociceptin. The opioid receptors are 40% identical to somatostatin… …   Wikipedia

  • Opioid — Endogenous opioid peptides Skeletal molecular images Adrenorphin Amidorphin Casomorphin …   Wikipedia

  • Buprenorphine — Systematic (IUPAC) name (2S) 2 [( ) (5R,6R,7R,14S) 9α cyclopropylmethyl 4,5 epoxy 6,14 ethano 3 hydroxy 6 methoxymorphinan 7 yl] 3,3 dimethylbutan 2 ol Clinical …   Wikipedia

  • Ноцицептин — Общие Химическая формула …   Википедия

  • Cholecystokinin receptor — cholecystokinin A receptor Identifiers Symbol CCKAR Entrez 886 HUGO …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.